Protective influence of mhc genes on diabetes in a tcr transgenic mouse model
FP4 — Training and Mobility of Researchers
- Duration
- 1997-01-15 → 1999-01-14
- EU contribution
- —
- Participants
- 2
- Scheme
- RGI
Lines connect the coordinator with its partners. CORDIS does not always give exact coordinates for projects before 2014. These points are placed at city or country level.
Project objective
In the NOD mouse, a valuable model for human IDDM, the diabetes susceptibility is linked to MHC II genes, but the mechanism(s) of influence at the T cell level are not yet clear. Using the established BDC2.5 TCR transgenic mouse line and making appropriate crosses into the B6, NOD and B6.H-2g7 background, 4 lines of mice could be obtained with homo- and heterozygous expression of the NOD MEIC H-2g7 or B6 MHC H-2b in the NOD or B6 background, respectively. The aim of this study is to investigate the protection mechanism(s) of the non-NOD MHC II Ab molecule on insulitis and IDDM. At first, two mice lines carrying knock-out alleles should be generates to confirm the direct role of the Ab molecule and to eliminate the contribution of non-transgenic TCRs. Furthermore, the T cells from the different mouse lines and the expression of MHC of MHC molecules in splenic antigen presenting cells (APSs)will be compared. Finally, the ability for these APSs to stimulate T cell proliferation and especially the influence on the Th1/Th2 balance should be investigated.
Original text from CORDIS.
Participants
Links
Data: CORDIS, © European Union
